Skip To Main Content
Sarandeep Boyanapalli on Muck Rack

Sarandeep Boyanapalli

As seen in: Wiley Online Library
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Sarandeep

Contact Sarandeep, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Accelerating Pediatric Oncology Drug Development: Advances in Clinical Pharmacology, Trial Design, Non-Clinical Evidence, and Regulatory Science

|
By Xiaoning Wang, Ya-Feng Wen PharmD, Sarandeep Boyanapalli
| Wiley Online Library Verified
Introduction The advancement in the understanding of cancer biology, novel treatment modalities, personalized medicine, and supportive care has increased the 5-year survival rate of pediatric cancers from 63% in the mid-1970s to 87% in 2015-2021 in the United States.1-3 As an example, for acute lymphocytic leukemia (ALL), the most common type of leukemia in children (ages 0-14 years) and adolescents (ages 15-19 years), the 5-year survival rate has steadily increased from 14% in the late 1960s...
Open in Who Shared Issue with article?
See all 1 articles